Thiogenesis Therapeutics’ MELAS Abstract Accepted for Late-Breaking News Presentation at Mitocon 2026
San Diego, California–(Newsfile Corp. – January 13, 2026) – Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) (“Thiogenesis”…
Browsing Tag
accepted
1 post